Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Current Assets: 2019-2024

Historic Current Assets for Legend Biotech (LEGN) over the last 6 years, with Dec 2024 value amounting to $1.3 billion.

  • Legend Biotech's Current Assets fell 8.00% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 8.00%. This contributed to the annual value of $1.3 billion for FY2024, which is 14.28% down from last year.
  • According to the latest figures from FY2024, Legend Biotech's Current Assets is $1.3 billion, which was down 14.28% from $1.5 billion recorded in FY2023.
  • Legend Biotech's 5-year Current Assets high stood at $1.5 billion for FY2023, and its period low was $593.9 million during FY2020.
  • Over the past 3 years, Legend Biotech's median Current Assets value was $1.3 billion (recorded in 2024), while the average stood at $1.3 billion.
  • As far as peak fluctuations go, Legend Biotech's Current Assets spiked by 186.79% in 2020, and later fell by 14.28% in 2024.
  • Over the past 5 years, Legend Biotech's Current Assets (Yearly) stood at $593.9 million in 2020, then skyrocketed by 59.92% to $949.9 million in 2021, then rose by 15.72% to $1.1 billion in 2022, then spiked by 36.27% to $1.5 billion in 2023, then fell by 14.28% to $1.3 billion in 2024.